SHREE GANESH REMEDIES
|
SHREE GANESH REMEDIES Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
---|---|---|---|---|
INCOME : | ||||
Gross Sales | ₹129 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
Sales | ₹128 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
Job Work/ Contract Receipts | - | - | - | - |
Processing Charges / Service Income | - | - | - | - |
Revenue from property development | - | - | - | - |
Other Operational Income | ₹1.09 Cr | - | - | - |
Less: Excise Duty | - | - | - | - |
Net Sales | ₹126 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
EXPENDITURE : | ||||
Increase/Decrease in Stock | ₹-4.88 Cr | ₹-39,340 Cr | ₹-1.98 Cr | ₹-1.98 Cr |
Raw Material Consumed | ₹62 Cr | ₹3,830,818 Cr | ₹20 Cr | ₹20 Cr |
Opening Raw Materials | ₹8.48 Cr | ₹220,411 Cr | ₹1.64 Cr | ₹1.64 Cr |
Purchases Raw Materials | ₹63 Cr | ₹3,712,176 Cr | ₹21 Cr | ₹21 Cr |
Closing Raw Materials | ₹10 Cr | ₹101,769 Cr | ₹1.89 Cr | ₹1.89 Cr |
Other Direct Purchases / Brought in cost | ₹1.28 Cr | - | - | - |
Other raw material cost | - | - | - | - |
Power & Fuel Cost | ₹6.39 Cr | ₹154,387 Cr | ₹0.85 Cr | ₹0.85 Cr |
Electricity & Power | ₹6.39 Cr | ₹143,413 Cr | ₹0.79 Cr | ₹0.79 Cr |
Oil, Fuel & Natural gas | - | ₹4,343 Cr | ₹0.05 Cr | ₹0.05 Cr |
Coals etc | - | - | - | - |
Other power & fuel | - | ₹6,632 Cr | ₹0.02 Cr | ₹0.02 Cr |
Employee Cost | ₹8.41 Cr | ₹289,908 Cr | ₹1.63 Cr | ₹1.63 Cr |
Salaries, Wages & Bonus | ₹7.66 Cr | ₹264,075 Cr | ₹1.51 Cr | ₹1.51 Cr |
Contributions to EPF & Pension Funds | ₹0.29 Cr | ₹12,591 Cr | ₹0.07 Cr | ₹0.07 Cr |
Workmen and Staff Welfare Expenses | ₹0.30 Cr | ₹6,488 Cr | ₹0.03 Cr | ₹0.03 Cr |
Other Employees Cost | ₹0.16 Cr | ₹6,754 Cr | ₹0.03 Cr | ₹0.03 Cr |
Other Manufacturing Expenses | ₹4.82 Cr | ₹69,661 Cr | ₹0.56 Cr | ₹0.56 Cr |
Sub-contracted / Out sourced services | ₹0.46 Cr | - | - | - |
Processing Charges | ₹2.05 Cr | - | - | - |
Repairs and Maintenance | ₹0.80 Cr | - | - | - |
Packing Material Consumed | ₹1.03 Cr | ₹49,329 Cr | ₹0.44 Cr | ₹0.44 Cr |
Other Mfg Exp | ₹0.47 Cr | ₹20,333 Cr | ₹0.12 Cr | ₹0.12 Cr |
General and Administration Expenses | ₹2.48 Cr | ₹693,101 Cr | ₹3.69 Cr | ₹3.69 Cr |
Rent , Rates & Taxes | ₹1.17 Cr | ₹13,804 Cr | ₹0.12 Cr | ₹0.12 Cr |
Insurance | ₹0.10 Cr | ₹6,380 Cr | ₹0.06 Cr | ₹0.06 Cr |
Printing and stationery | - | ₹3,899 Cr | ₹0.02 Cr | ₹0.02 Cr |
Professional and legal fees | ₹0.69 Cr | ₹19,757 Cr | ₹0.19 Cr | ₹0.19 Cr |
Traveling and conveyance | ₹0.08 Cr | ₹5,287 Cr | ₹0.04 Cr | ₹0.04 Cr |
Other Administration | ₹0.45 Cr | ₹643,974 Cr | ₹3.26 Cr | ₹3.26 Cr |
Selling and Distribution Expenses | ₹3.95 Cr | ₹123,339 Cr | ₹1.18 Cr | ₹1.18 Cr |
Advertisement & Sales Promotion | ₹1.36 Cr | ₹13,226 Cr | ₹0.11 Cr | ₹0.11 Cr |
Sales Commissions & Incentives | ₹0.20 Cr | ₹17,550 Cr | ₹0.14 Cr | ₹0.14 Cr |
Freight and Forwarding | ₹2.39 Cr | ₹92,161 Cr | ₹0.94 Cr | ₹0.94 Cr |
Handling and Clearing Charges | - | - | - | - |
Other Selling Expenses | - | ₹401 Cr | ₹0.00 Cr | ₹0.00 Cr |
Miscellaneous Expenses | ₹0.60 Cr | ₹28,248 Cr | ₹0.17 Cr | ₹0.17 Cr |
Bad debts /advances written off | - | - | - | - |
Provision for doubtful debts | ₹0.02 Cr | - | - | - |
Losson disposal of fixed assets(net) | ₹0.01 Cr | - | ₹0.00 Cr | ₹0.00 Cr |
Losson foreign exchange fluctuations | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - |
Other Miscellaneous Expenses | ₹0.57 Cr | ₹28,248 Cr | ₹0.17 Cr | ₹0.17 Cr |
Less: Expenses Capitalised | - | - | - | - |
Total Expenditure | ₹84 Cr | ₹5,150,123 Cr | ₹27 Cr | ₹27 Cr |
Operating Profit (Excl OI) | ₹42 Cr | ₹1,251,750 Cr | ₹8.74 Cr | ₹8.74 Cr |
Other Income | ₹3.07 Cr | ₹390,970 Cr | ₹1.17 Cr | ₹1.17 Cr |
Interest Received | ₹0.07 Cr | ₹11,349 Cr | ₹0.11 Cr | ₹0.11 Cr |
Dividend Received | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - |
Profits on sale of Investments | - | - | - | - |
Provision Written Back | - | - | - | - |
Foreign Exchange Gains | ₹2.15 Cr | ₹216,613 Cr | ₹0.73 Cr | ₹0.73 Cr |
Others | ₹0.86 Cr | ₹163,008 Cr | ₹0.32 Cr | ₹0.32 Cr |
Operating Profit | ₹45 Cr | ₹1,642,720 Cr | ₹9.91 Cr | ₹9.91 Cr |
Interest | ₹0.61 Cr | ₹54,250 Cr | ₹0.20 Cr | ₹0.20 Cr |
InterestonDebenture / Bonds | - | - | - | - |
Interest on Term Loan | ₹0.54 Cr | - | - | - |
Intereston Fixed deposits | - | - | - | - |
Bank Charges etc | ₹0.06 Cr | ₹4,913 Cr | ₹0.03 Cr | ₹0.03 Cr |
Other Interest | ₹0.01 Cr | ₹49,338 Cr | ₹0.18 Cr | ₹0.18 Cr |
PBDT | ₹44 Cr | ₹1,588,469 Cr | ₹9.70 Cr | ₹9.70 Cr |
Depreciation | ₹6.11 Cr | ₹229,473 Cr | ₹1.04 Cr | ₹1.04 Cr |
Profit Before Taxation & Exceptional Items | ₹38 Cr | ₹1,358,996 Cr | ₹8.67 Cr | ₹8.67 Cr |
Exceptional Income / Expenses | - | - | - | - |
Profit Before Tax | ₹38 Cr | ₹1,358,996 Cr | ₹8.67 Cr | ₹8.67 Cr |
Provision for Tax | ₹10 Cr | ₹311,940 Cr | ₹2.43 Cr | ₹2.43 Cr |
Current Income Tax | ₹9.33 Cr | ₹317,573 Cr | ₹2.19 Cr | ₹2.19 Cr |
Deferred Tax | ₹0.67 Cr | ₹-5,633 Cr | ₹0.24 Cr | ₹0.24 Cr |
Other taxes | ₹0.05 Cr | - | - | - |
Profit After Tax | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
Extra items | - | - | - | - |
Minority Interest | - | - | - | - |
Share of Associate | - | - | - | - |
Other Consolidated Items | - | - | - | - |
Consolidated Net Profit | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
Adjustments to PAT | - | - | - | - |
Profit Balance B/F | ₹59 Cr | ₹1,800,323 Cr | ₹13 Cr | ₹13 Cr |
Appropriations | ₹87 Cr | ₹2,847,379 Cr | ₹19 Cr | ₹19 Cr |
General Reserves | - | - | - | - |
Proposed Equity Dividend | - | - | - | - |
Corporate dividend tax | - | - | - | - |
Other Appropriation | ₹0.58 Cr | ₹233,318 Cr | ₹1.09 Cr | ₹1.09 Cr |
Equity Dividend % | - | ₹15.00 | ₹12.50 | ₹12.50 |
Earnings Per Share | ₹21.89 | ₹11.67 | ₹6.95 | ₹6.95 |
Adjusted EPS | ₹21.89 | ₹8.66 | ₹5.16 | ₹5.16 |
Compare Income Statement of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹719.5 Cr | -4.3% | 7.7% | -35.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -4.3% |
7.7% |
-35.4% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses